171 related articles for article (PubMed ID: 18809389)
21. Detection of P2Y(14) protein in platelets and investigation of the role of P2Y(14) in platelet function in comparison with the EP(3) receptor.
Dovlatova N; Wijeyeratne YD; Fox SC; Manolopoulos P; Johnson AJ; White AE; Latif ML; Ralevic V; Heptinstall S
Thromb Haemost; 2008 Aug; 100(2):261-70. PubMed ID: 18690346
[TBL] [Abstract][Full Text] [Related]
22. The P2 receptors and congenital platelet function defects.
Cattaneo M
Semin Thromb Hemost; 2005 Apr; 31(2):168-73. PubMed ID: 15852220
[TBL] [Abstract][Full Text] [Related]
23. Dual effect of nucleotides on P2Y receptors.
Sak K; Barnard EA; Järv J
IUBMB Life; 2000 Aug; 50(2):99-103. PubMed ID: 11185965
[TBL] [Abstract][Full Text] [Related]
24. Distinct P2Y receptor subtypes regulate calcium signaling in human retinal pigment epithelial cells.
Tovell VE; Sanderson J
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):350-7. PubMed ID: 18172112
[TBL] [Abstract][Full Text] [Related]
25. Arg333 and Arg334 in the COOH terminus of the human P2Y1 receptor are crucial for Gq coupling.
Ding Z; Tuluc F; Bandivadekar KR; Zhang L; Jin J; Kunapuli SP
Am J Physiol Cell Physiol; 2005 Mar; 288(3):C559-67. PubMed ID: 15509659
[TBL] [Abstract][Full Text] [Related]
26. Adenosine-derived non-phosphate antagonists for P2Y(1) purinoceptors.
Sak K; Uri A; Enkvist E; Raidaru G; Subbi J; Kelve M; Järv J
Biochem Biophys Res Commun; 2000 Jun; 272(2):327-31. PubMed ID: 10833413
[TBL] [Abstract][Full Text] [Related]
27. Interaction of the active metabolite of prasugrel, R-138727, with cysteine 97 and cysteine 175 of the human P2Y12 receptor.
Algaier I; Jakubowski JA; Asai F; von Kügelgen I
J Thromb Haemost; 2008 Nov; 6(11):1908-14. PubMed ID: 18752581
[TBL] [Abstract][Full Text] [Related]
28. RhoA/ROCK I signalling downstream of the P2Y13 ADP-receptor controls HDL endocytosis in human hepatocytes.
Malaval C; Laffargue M; Barbaras R; Rolland C; Peres C; Champagne E; Perret B; Tercé F; Collet X; Martinez LO
Cell Signal; 2009 Jan; 21(1):120-7. PubMed ID: 18948190
[TBL] [Abstract][Full Text] [Related]
29. P2y(12), a new platelet ADP receptor, target of clopidogrel.
Savi P; Labouret C; Delesque N; Guette F; Lupker J; Herbert JM
Biochem Biophys Res Commun; 2001 May; 283(2):379-83. PubMed ID: 11327712
[TBL] [Abstract][Full Text] [Related]
30. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
Béres BJ; Tóth-Zsámboki E; Vargová K; László A; Masszi T; Kerecsen G; Préda I; Kiss RG
Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527
[TBL] [Abstract][Full Text] [Related]
31. Use of radiolabeled 2-methylthio-ADP to study P2Y receptors on platelets and cell lines.
Savi P; Herbert JM
Methods Mol Biol; 2004; 273():115-24. PubMed ID: 15308797
[No Abstract] [Full Text] [Related]
32. Nucleotide P2Y1 receptor regulates EGF receptor mitogenic signaling and expression in epithelial cells.
Buvinic S; Bravo-Zehnder M; Boyer JL; Huidobro-Toro JP; González A
J Cell Sci; 2007 Dec; 120(Pt 24):4289-301. PubMed ID: 18057028
[TBL] [Abstract][Full Text] [Related]
33. Augmentation of U46619 induced human platelet aggregation by aspirin.
Kim JM; Koo YK; Jin J; Lee YY; Park S; Yun-Choi HS
Platelets; 2009 Mar; 20(2):111-9. PubMed ID: 19235053
[TBL] [Abstract][Full Text] [Related]
34. Clopidogrel versus prasugrel in rabbits. Effects on thrombosis, haemostasis, platelet function and response variability.
Wong PC; Crain EJ; Watson CA; Hua J; Schumacher WA; Rehfuss R
Thromb Haemost; 2009 Jan; 101(1):108-15. PubMed ID: 19132196
[TBL] [Abstract][Full Text] [Related]
35. Preclinical and clinical studies with selective reversible direct P2Y12 antagonists.
van Giezen JJ; Humphries RG
Semin Thromb Hemost; 2005 Apr; 31(2):195-204. PubMed ID: 15852223
[TBL] [Abstract][Full Text] [Related]
36. Identification of a novel transmembrane domain involved in the negative modulation of mGluR1 using a newly discovered allosteric mGluR1 antagonist, 3-cyclohexyl-5-fluoro-6-methyl-7-(2-morpholin-4-ylethoxy)-4H-chromen-4-one.
Fukuda J; Suzuki G; Kimura T; Nagatomi Y; Ito S; Kawamoto H; Ozaki S; Ohta H
Neuropharmacology; 2009 Sep; 57(4):438-45. PubMed ID: 19559036
[TBL] [Abstract][Full Text] [Related]
37. ADP acting on P2Y13 receptors is a negative feedback pathway for ATP release from human red blood cells.
Wang L; Olivecrona G; Götberg M; Olsson ML; Winzell MS; Erlinge D
Circ Res; 2005 Feb; 96(2):189-96. PubMed ID: 15604418
[TBL] [Abstract][Full Text] [Related]
38. Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270.
Ding Z; Kim S; Dorsam RT; Jin J; Kunapuli SP
Blood; 2003 May; 101(10):3908-14. PubMed ID: 12560222
[TBL] [Abstract][Full Text] [Related]
39. The active metabolite of prasugrel effectively blocks the platelet P2Y12 receptor and inhibits procoagulant and pro-inflammatory platelet responses.
Judge HM; Buckland RJ; Sugidachi A; Jakubowski JA; Storey RF
Platelets; 2008 Mar; 19(2):125-33. PubMed ID: 18297550
[TBL] [Abstract][Full Text] [Related]
40. The functional role of cysteines adjacent to the NRY motif of the human MT1 melatonin receptor.
Kokkola T; Salo OM; Poso A; Laitinen JT
J Pineal Res; 2005 Aug; 39(1):1-11. PubMed ID: 15978051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
